Literature DB >> 19322688

[Prevalence of cognitive deterioration in people over 80-years-old: COGMANLLEU study].

E Bufill1, A Bartés, A Moral, T Casadevall, M Codinachs, E Zapater, J C Rovira, R Pérez, P Roura, R Blesa.   

Abstract

INTRODUCTION: We want to detect the prevalence of cognitive prevalence deterioration in the elderly population of 80-years-old or older, their grade of deterioration and the causal pathogenic entity.
DESIGN: a cross-sectional population study, including a first phase of screening and a second one of diagnosis confirmation. STUDY
SUBJECTS: a total of 877 elderly people of 80-years-old or older belonging to the basic health care area of Manlleu (Osona, Catalonia midlands). In the first phase, relatives and/or caregivers were interviewed, and the participating subjects underwent a set of tests. Those who obtained 24 points or less on the Mini-Mental State Examination (MMSE) and/or an equal Global Deterioration Scale (GDS) or over 3 were admitted to the second phase. During the second phase, a general and a neurological examination were performed, along with blood tests, cranial computed tomography scan and a neuropsychological study. DSM-IV criteria were used for dementia diagnosis, NINCDS-ADRA criteria for Alzheimer's disease (AD) and NINCS-AIREN for vascular dementia.
RESULTS: Half of the people over 80-years-old had cognitive deterioration. One-fourth had dementia. A total of 70.3% of these dementias corresponded to AD (47.2% AD without vascular lesions and 23.1% AD with vascular lesions) and 12% corresponded to vascular dementia. The percentage of other degenerative dementias was 17.6%. Age and gender were observed to be associated to dementia.
CONCLUSIONS: The prevalence of dementia in the COGMANLLEU study is similar to other European studies. AE is the most frequent dementia.

Entities:  

Mesh:

Year:  2009        PMID: 19322688

Source DB:  PubMed          Journal:  Neurologia        ISSN: 0213-4853            Impact factor:   3.109


  3 in total

1.  Prevalence of Drug-Induced Xerostomia in Older Adults with Cognitive Impairment or Dementia: An Observational Study.

Authors:  José Antonio Gil-Montoya; Rocío Barrios; Inés Sánchez-Lara; Cristobal Carnero-Pardo; Francisco Fornieles-Rubio; Juan Montes; Miguel Angel Gonzalez-Moles; Manuel Bravo
Journal:  Drugs Aging       Date:  2016-08       Impact factor: 3.923

Review 2.  The neuroinflammatory response of postoperative cognitive decline.

Authors:  Susana Vacas; Vincent Degos; Xiaomei Feng; Mervyn Maze
Journal:  Br Med Bull       Date:  2013-04-04       Impact factor: 4.291

3.  Prevalence of cognitive impairment in individuals aged over 65 in an urban area: DERIVA study.

Authors:  Emiliano Rodríguez-Sánchez; Sara Mora-Simón; María C Patino-Alonso; Ricardo García-García; Alfonso Escribano-Hernández; Luis García-Ortiz; Ma Victoria Perea-Bartolomé; Manuel A Gómez-Marcos
Journal:  BMC Neurol       Date:  2011-11-17       Impact factor: 2.474

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.